Muscle protein breakdown during endotoxemia in rats and after treatment with interleukin-1 receptor antagonist (IL-1ra)

O. Zamir, P. O. Hasselgren, W. O'Brien, R. C. Thompson, J. E. Fischer, D. W. Wilmore, S. F. Lowry, Basil A Pruitt

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

The purpose of this study was to examine the effect of endotoxemia on muscle protein degradation and to test the hypothesis that muscle proteolysis during endotoxemia is regulated by interleukin-1 (IL-1). Both total and myofibrillar protein breakdown rates in incubated extensor digitorum longus muscles were increased after the subcutaneous injection of 0.1 or 1.0 mg/kg endotoxin in rats. The endotoxin-induced increase in muscle protein breakdown was blunted by IL-1 receptor antagonist, administered intraperitoneally at a total dose of 45 or 105 mg/kg. Results suggest that endotoxemia in rats gives rise to sepsislike changes in muscle protein breakdown. Increased muscle protein breakdown during endotoxemia may be regulated, at least in part, by IL-1.

Original languageEnglish (US)
Pages (from-to)381-387
Number of pages7
JournalAnnals of Surgery
Volume216
Issue number3
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

Endotoxemia
Interleukin-1 Receptors
Muscle Proteins
Interleukin-1
Endotoxins
Proteolysis
Muscles
Subcutaneous Injections
Therapeutics
Proteins

ASJC Scopus subject areas

  • Surgery

Cite this

Zamir, O., Hasselgren, P. O., O'Brien, W., Thompson, R. C., Fischer, J. E., Wilmore, D. W., ... Pruitt, B. A. (1992). Muscle protein breakdown during endotoxemia in rats and after treatment with interleukin-1 receptor antagonist (IL-1ra). Annals of Surgery, 216(3), 381-387. https://doi.org/10.1097/00000658-199209000-00018

Muscle protein breakdown during endotoxemia in rats and after treatment with interleukin-1 receptor antagonist (IL-1ra). / Zamir, O.; Hasselgren, P. O.; O'Brien, W.; Thompson, R. C.; Fischer, J. E.; Wilmore, D. W.; Lowry, S. F.; Pruitt, Basil A.

In: Annals of Surgery, Vol. 216, No. 3, 1992, p. 381-387.

Research output: Contribution to journalArticle

Zamir, O, Hasselgren, PO, O'Brien, W, Thompson, RC, Fischer, JE, Wilmore, DW, Lowry, SF & Pruitt, BA 1992, 'Muscle protein breakdown during endotoxemia in rats and after treatment with interleukin-1 receptor antagonist (IL-1ra)', Annals of Surgery, vol. 216, no. 3, pp. 381-387. https://doi.org/10.1097/00000658-199209000-00018
Zamir, O. ; Hasselgren, P. O. ; O'Brien, W. ; Thompson, R. C. ; Fischer, J. E. ; Wilmore, D. W. ; Lowry, S. F. ; Pruitt, Basil A. / Muscle protein breakdown during endotoxemia in rats and after treatment with interleukin-1 receptor antagonist (IL-1ra). In: Annals of Surgery. 1992 ; Vol. 216, No. 3. pp. 381-387.
@article{e0c38a6c4c3f424490b6d02a5b80d71a,
title = "Muscle protein breakdown during endotoxemia in rats and after treatment with interleukin-1 receptor antagonist (IL-1ra)",
abstract = "The purpose of this study was to examine the effect of endotoxemia on muscle protein degradation and to test the hypothesis that muscle proteolysis during endotoxemia is regulated by interleukin-1 (IL-1). Both total and myofibrillar protein breakdown rates in incubated extensor digitorum longus muscles were increased after the subcutaneous injection of 0.1 or 1.0 mg/kg endotoxin in rats. The endotoxin-induced increase in muscle protein breakdown was blunted by IL-1 receptor antagonist, administered intraperitoneally at a total dose of 45 or 105 mg/kg. Results suggest that endotoxemia in rats gives rise to sepsislike changes in muscle protein breakdown. Increased muscle protein breakdown during endotoxemia may be regulated, at least in part, by IL-1.",
author = "O. Zamir and Hasselgren, {P. O.} and W. O'Brien and Thompson, {R. C.} and Fischer, {J. E.} and Wilmore, {D. W.} and Lowry, {S. F.} and Pruitt, {Basil A}",
year = "1992",
doi = "10.1097/00000658-199209000-00018",
language = "English (US)",
volume = "216",
pages = "381--387",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Muscle protein breakdown during endotoxemia in rats and after treatment with interleukin-1 receptor antagonist (IL-1ra)

AU - Zamir, O.

AU - Hasselgren, P. O.

AU - O'Brien, W.

AU - Thompson, R. C.

AU - Fischer, J. E.

AU - Wilmore, D. W.

AU - Lowry, S. F.

AU - Pruitt, Basil A

PY - 1992

Y1 - 1992

N2 - The purpose of this study was to examine the effect of endotoxemia on muscle protein degradation and to test the hypothesis that muscle proteolysis during endotoxemia is regulated by interleukin-1 (IL-1). Both total and myofibrillar protein breakdown rates in incubated extensor digitorum longus muscles were increased after the subcutaneous injection of 0.1 or 1.0 mg/kg endotoxin in rats. The endotoxin-induced increase in muscle protein breakdown was blunted by IL-1 receptor antagonist, administered intraperitoneally at a total dose of 45 or 105 mg/kg. Results suggest that endotoxemia in rats gives rise to sepsislike changes in muscle protein breakdown. Increased muscle protein breakdown during endotoxemia may be regulated, at least in part, by IL-1.

AB - The purpose of this study was to examine the effect of endotoxemia on muscle protein degradation and to test the hypothesis that muscle proteolysis during endotoxemia is regulated by interleukin-1 (IL-1). Both total and myofibrillar protein breakdown rates in incubated extensor digitorum longus muscles were increased after the subcutaneous injection of 0.1 or 1.0 mg/kg endotoxin in rats. The endotoxin-induced increase in muscle protein breakdown was blunted by IL-1 receptor antagonist, administered intraperitoneally at a total dose of 45 or 105 mg/kg. Results suggest that endotoxemia in rats gives rise to sepsislike changes in muscle protein breakdown. Increased muscle protein breakdown during endotoxemia may be regulated, at least in part, by IL-1.

UR - http://www.scopus.com/inward/record.url?scp=0026793224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026793224&partnerID=8YFLogxK

U2 - 10.1097/00000658-199209000-00018

DO - 10.1097/00000658-199209000-00018

M3 - Article

VL - 216

SP - 381

EP - 387

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 3

ER -